Search results
5 cze 2018 · Both the pooled crude RR and adjusted aRR suggested a statistically significant increased risk of acquisition of HPV (pooled RR = 1.55, 95% CI: 1.29 to 1.88; pooled aRR = 2.46, 95% CI: 1.86 to 3.26), HR‐HPV (pooled RR = 2.20, 95% CI: 1.90 to 2.54; pooled aRR = 1.87, 95% CI: 1.32 to 2.67) and HPV‐16 (pooled RR 2.10, 95% CI: 1.63 to 2.67 ...
The term ocular surface squamous neoplasia (OSSN) comprises a wide variety of lesions of the conjunctiva and cornea, ranging from mild dysplasia to carcinoma in situ and, in a later stage, invasive squamous cell carcinoma (SCC; Nagaiah et al, 2010; Di Girolamo, 2012).. Although OSSN are rare conditions, they are among the most frequent ocular surface tumours (Grossniklaus et al, 1987), and an ...
17 lut 2023 · The human papillomavirus (HPV) and HIV are viruses that mainly spread through sexual contact. They are different viruses with different symptoms. But, having HIV can increase the risk of...
1 paź 2013 · Abstract. Background: The frequency of ocular surface squamous neoplasias (OSSNs) has been increasing in populations with a high prevalence of infection with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and infection with human papillomavirus (HPV).
1 lip 2007 · Clinicians should be aware of the most important changes in ocular complications of HIV/AIDS in the era of HAART: decreased but still significant risk of cytomegalovirus (CMV) retinitis; immune-recovery uveitis; and possible discontinuation of anti-CMV therapy in patients with immune recovery.
Human papillomavirus (HPV) infection has been implicated as a primary cause of lesions in the anogenital region, skin, oropharynx and respiratory tract. Additionally, the role of HPV in the pathogenesis of ocular surface disease has also been extensively studied.
These results provide evidence for synergistic HIV and HPV interactions of clinical and public health relevance. HPV vaccination may directly benefit PLHIV, and help control both HPV and HIV at the population level in high prevalence settings.
